Home
>
National Drug Code (NDC)
>
Neulasta
Neulasta - 55513-190-01 - (pegfilgrastim)
Drug Information of Neulasta
| Product NDC: | 55513-190 |
| Proprietary Name: | Neulasta |
| Non Proprietary Name: | pegfilgrastim |
| Active Ingredient(s): | 6 mg/.6mL & nbsp; pegfilgrastim |
| Administration Route(s): | SUBCUTANEOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Neulasta
| Product NDC: | 55513-190 |
| Labeler Name: | AMGEN INC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA125031 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20020401 |
Package Information of Neulasta
| Package NDC: | 55513-190-01 |
| Package Description: | 1 BLISTER PACK in 1 BOX (55513-190-01) > 1 SYRINGE in 1 BLISTER PACK > .6 mL in 1 SYRINGE |
NDC Information of Neulasta
| NDC Code | 55513-190-01 |
| Proprietary Name | Neulasta |
| Package Description | 1 BLISTER PACK in 1 BOX (55513-190-01) > 1 SYRINGE in 1 BLISTER PACK > .6 mL in 1 SYRINGE |
| Product NDC | 55513-190 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | pegfilgrastim |
| Dosage Form Name | INJECTION |
| Route Name | SUBCUTANEOUS |
| Start Marketing Date | 20020401 |
| Marketing Category Name | BLA |
| Labeler Name | AMGEN INC |
| Substance Name | PEGFILGRASTIM |
| Strength Number | 6 |
| Strength Unit | mg/.6mL |
| Pharmaceutical Classes | Granulocyte Colony-Stimulating Factor [Chemical/Ingredient],Granulocyte-Macrophage Colony-Stimulating Factor [Chemical/Ingredient],Increased Myeloid Cell Production [PE],Leukocyte Growth Factor [EPC] |
